Although the 2020 edition of the forum was suspended due to COVID, now, in 2021 it will be organised on 20-22 April as an online event, broadcast live from Barcelona.
The MedTech Forum is the largest health and medical technology industry conferences in Europe and a key event since 2007. Industry leaders, leading innovators and investors join to discuss the future opportunities in the medical technology sector. It is organised by MedTech Europe, which is the European trade association representing the medical technology industries, from diagnosis to cure. It represents Diagnostics and Medical Devices manufacturers operating in Europe.
This Year’s Programme
As part of the Forum’s programme, and among many other subjects, critical issues for the industry will be treated, such as:
- The increasing number of novel innovation drivers (Start-ups, Incubators, Collaborations etc.) “disrupting” the traditional model of large corporate R&D units. This happens as a shift takes place from classical technology to complex systems involving digital tools and encompassing the entire patient journey. New roles are emerging, as is the case with collaborations between public, private and academic drivers of innovation.
- The Innovative Health Initiative: It is the next European Public Private Partnership for Health Innovation, built on the success of IMI (Innovative Medicines Initiative) and ECSEL (Electronic Components and Systems for European Leadership) partnerships. A multi sectorial approach is set up for the first time to integrate pharma and medtech sectors to bridge the gap to address today’s health and translational challenges. Expectations are high for the pharma and medtech companies to jointly deliver breakthrough innovation for the benefit of patients and make Europe again a place for healthtech innovation. The Innovative Health Initiative is expected to kick off in just a few months. So planning on how to best take advantage of this unprecedented opportunity becomes paramount.
- On next 26 May 2021 the new Medical Device Regulation’s (MDR) will finally reach its Date of Application, marking the end of the MDR transition period. A lot has been accomplished during the past 4 years. The bulk of MDR certification is actually still expected and implementation remains challenging with many compliance deadlines still to come (e.g. Eudamed) and many regulatory building block not yet fully operational or in place. Getting to know what has been achieved during the MDR transition period, watching in retrospect COVID-19 and its impact on MDR implementation, or which Acts and Guidance documents are still needed to make the MDR work, the state of the Play on national MDR adaption laws and scenarios that are likely to unfold in the coming months/years are only examples of the challenges MDR poses.
Nanoker, our Ceramics, and Medical Devices
We are delighted to join the Forum and learn from top-level speakers within the medical technology industry and benefit from unique networking opportunities.
Advanced ceramics show unique intrinsic properties in biomedical applications. Due to which the global medical ceramics market is growing fast (expected US$ 24 Bn by 2025). Nanoker entered this market since its very incorporation (coloured CADCAM blanks) and, from 2017, our growth focus pivoted to this segment, with particular emphasis in dental implants market with NACRE, an all ceramic nanocomposite, disruptive, root-form, versatile monoblock implant that has already shown extremely good performance under real conditions, and is set to hit the market in 2022 upon completion of CE/MDR marking by IMQ Italian MDR adapted Notified Body.